Education
About Us
Working with TipRanks
Follow Us
Electromed (ELMD)
:ELMD
ELMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$13.74 - $35.56
Previous CloseN/A
Volume34.94K
Average Volume (3M)93.00K
Market Cap
$170.41M
Enterprise Value$84.91M
Total Cash (Recent Filing)$15.24M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)25.5
Beta0.58
Next Earnings
Sep 02, 2025EPS Estimate
0.22Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.21
Shares Outstanding8,386,115
10 Day Avg. Volume178,784
30 Day Avg. Volume92,998
Financial Highlights & Ratios
PEG Ratio0.77
Price to Book (P/B)2.41
Price to Sales (P/S)0.00
P/FCF Ratio-226.05
Enterprise Value/Market Cap0.50
Enterprise Value/Revenue0.36
Enterprise Value/Gross Profit1.78
Enterprise Value/Ebitda2.37
Forecast
1Y Price Target
$32.50Price Target Upside56.40% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Electromed News
PremiumCompany Announcements
Electromed’s Earnings Call Highlights Growth and Strategic Initiatives
PremiumCompany Announcements
Electromed Reports Strong Q3 2025 Financial Growth
PremiumCompany Announcements
Electromed Reports Strong Q3 2025 Financial Results
PremiumCompany Announcements
Electromed Announces $5 Million Share Buyback Program
Bulls Say, Bears Say
Bulls Say
Financial HealthThe company has $16M in cash, $23M in accounts receivable, no debt, and is the final remaining pure-play in the HFCWO space, making it an attractive takeout target for a larger medtech strategy.
Management And OperationsThe new management team and board have accomplished growth through product enhancements, sales force productivity, leaner and more efficient reimbursement, market development efforts, and streamlined operations.
Bears Say
Market PenetrationAs the Company continues to gain traction in the underpenetrated bronchiectasis market, multiple expansion is warranted.
Options Prices
Currently, No data available
---
Ownership Overview
8.79% Insiders
8.83% Mutual Funds
11.32% Other Institutional Investors
65.74% Public Companies and Individual Investors
ELMD FAQ
What was Electromed’s price range in the past 12 months?
Electromed lowest stock price was $13.74 and its highest was $35.56 in the past 12 months.
What is Electromed’s market cap?
Electromed’s market cap is $170.41M.
When is Electromed’s upcoming earnings report date?
Electromed’s upcoming earnings report date is Sep 02, 2025 which is in 59 days.
How were Electromed’s earnings last quarter?
Electromed released its earnings results on May 13, 2025. The company reported $0.21 earnings per share for the quarter, beating the consensus estimate of $0.202 by $0.008.
Is Electromed overvalued?
According to Wall Street analysts Electromed’s price is currently Undervalued.
Does Electromed pay dividends?
Electromed does not currently pay dividends.
What is Electromed’s EPS estimate?
Electromed’s EPS estimate is 0.22.
How many shares outstanding does Electromed have?
Electromed has 8,386,115 shares outstanding.
What happened to Electromed’s price movement after its last earnings report?
Electromed reported an EPS of $0.21 in its last earnings report, beating expectations of $0.202. Following the earnings report the stock price went down -15.287%.
Which hedge fund is a major shareholder of Electromed?
Currently, no hedge funds are holding shares in ELMD
Electromed Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$32.50 (56.40% Upside)
$32.50 (56.40% Upside)
Blogger Sentiment
Bullish
ELMD Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 18.4K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 1.1%
Last 30 Days ▲ 7.0%
Last 30 Days ▲ 7.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
45.14%
12-Months-Change
Fundamentals
Return on Equity
16.56%
Trailing 12-Months
Asset Growth
7.26%
Trailing 12-Months
Company Description
Electromed
Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.
ELMD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Electromed reported strong revenue and net income growth for the 10th consecutive quarter, with significant improvements in gross profit and successful operational initiatives, including a share repurchase program. However, there were declines in non-homecare revenue and an increase in SG&A expenses.Read More>ELMD Stock 12 Month Forecast
Average Price Target
$32.50
▲(56.40%Upside)